MARGETUXIMAB-CMKB

27 reported adverse events

Drug classes: HER2/neu Receptor Antagonist [EPC]

These side effects are most commonly reported by patients taking MARGETUXIMAB-CMKB:

# Side effect Count
0 DEATH 5
1 DISEASE PROGRESSION 5
2 CHILLS 3
3 INFUSION RELATED REACTION 2
4 ABDOMINAL PAIN 1
5 ALOPECIA 1
6 ANAPHYLACTIC REACTION 1
7 ASTHENIA 1
8 BLOOD PRESSURE DECREASED 1
9 CARDIAC DISORDER 1
See all common reactions for MARGETUXIMAB-CMKB

MARGETUXIMAB-CMKB is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 NONINFECTIVE GINGIVITIS 1 0.0007
1 TERMINAL STATE 1 0.0001
2 METASTASES TO CENTRAL NERVOUS SYSTEM 1 0.0001
3 DISEASE PROGRESSION 5 0.0000
4 INFUSION RELATED REACTION 2 0.0000
5 CHILLS 3 0.0000
6 ANAPHYLACTIC REACTION 1 0.0000
7 BLOOD PRESSURE DECREASED 1 0.0000
8 NEOPLASM MALIGNANT 1 0.0000
9 TREATMENT FAILURE 1 0.0000
See all enriched reactions for MARGETUXIMAB-CMKB